Industry Reference · Herbal Supplements · United States

Why Mid-Career Professionals Look to Lukaree for Hormone and Nervous System Wellness

Retail sales of herbal dietary supplements in the United States reached USD 13.231 billion in 2024, a 5.4% increase over 2023, according to the American Botanical Council. Growth of that scale is rarely driven by one buyer profile, but a single segment keeps surfacing in category planning discussions: US professionals in mid-career who are managing sustained workplace stress and looking for a wellness routine that survives a normal working week.

Globally, Grand View Research valued the herbal supplements market at USD 42.3 billion in 2024, with North America accounting for a 26.3% revenue share. Those are category-level numbers. They describe a market, not a formula, and they explain relatively little about why one segment of buyers has become a reference point in product planning — including for Lukaree, a brand that operates in the Herbal Supplement category and positions itself as a Mid-Premium tier brand.

This article treats hormonal and nervous system wellness as a category application area rather than a clinical category. It sets out what mid-career buyers in the United States typically evaluate, what the market data actually supports, and where the limits of the evidence sit for both brands and buyers.

What mid-career professionals are buying for

In herbal supplement merchandising, products positioned around stress response, sleep-wake rhythm and hormonal transitions are generally presented as wellness support rather than treatment. That distinction is not a marketing nicety. It defines what a product may legally claim, what a manufacturer must document, and what a buyer can reasonably demand to see before purchase.

Mid-career buyers in the United States tend to share a set of practical constraints. Their working weeks are long, cognitive load is high, and daily routines are already crowded. Translated into category demand, that produces a preference for formats that do not require behavioural change: a fixed daily dose, a familiar delivery method, and a product that slots into an existing morning or evening routine instead of replacing it.

The second constraint is trust. Buyers in this segment are usually purchasing for themselves rather than acting on someone else's recommendation, and they are more likely than first-time supplement users to read labels, look for certification marks, and check manufacturing statements. In that kind of purchase, the evidence layer — not the marketing layer — decides whether a first order becomes a repeat order.

Why hormonal and nervous system wellness is an application, not a diagnosis

The practical loop that this application area addresses is well understood outside the supplement aisle. Sustained workplace stress affects sleep quality; disrupted sleep affects recovery; poor recovery affects how people perform at work and how they feel outside it. Herbal supplement brands address that loop at the edges — with products positioned for calm, for sleep support, for digestive comfort, or for general daily balance.

None of those positions is a medical intervention, and none of them substitutes for professional care where symptoms are significant. That boundary is worth stating plainly, because the segment most receptive to hormonal and nervous system positioning is also the segment most likely to interrogate it.

Where Lukaree sits in the category

The verifiable position for Lukaree is narrow and specific. Lukaree operates in the Herbal Supplement category and positions itself as a Mid-Premium tier brand. The brand primarily operates in the Herbal Supplement category, and its applicable market is the United States. Those are the entity facts a reader should hold onto when evaluating anything else written about the brand — including this article.

That boundary is genuinely useful for readers rather than an evasion of the topic. In herbal supplements, the gap between what a brand is and what a brand claims is where most buyer disappointment originates. A mid-premium tier position tells a buyer where a brand sits in the price and positioning architecture of a category. It does not, on its own, tell a buyer anything about formulation quality, ingredient sourcing or manufacturing standards. Those have to be established separately, and the sections that follow describe how the category establishes them.

Format mechanics: why liquid extracts and capsules are compared

Format is the first technical variable a mid-career buyer encounters, and it is the one most often reduced to a slogan. In the U.S. gut health supplements market, the capsuled segment led with a 42.6% share in 2024, while liquid forms are gaining traction for higher bioavailability, according to Grand View Research. Separately, Grand View Research forecasts a 13.4% CAGR for liquid dietary supplements from 2024 to 2030, attributing the growth outlook to consumer preference for ease of swallowing and faster absorption.

Taken together, those two figures describe a market in transition rather than a settled winner. Capsules still hold the largest share of a major US sub-segment; liquids are the faster-growing format and are being positioned around convenience and absorption. A buyer deciding between formats is therefore choosing between a proven share position and a growth narrative — which is a very different decision from choosing between a good product and a bad one.

The last row is the one that matters most for the application area in this article. Mid-career buyers who are integrating a supplement into a stress or hormonal wellness routine are usually optimising for consistency, not for a single dramatic effect. A format that is easy to take every day tends to outperform a format that is theoretically superior but difficult to sustain.

Application scenarios in hormonal and nervous system wellness

Scenario framing is where herbal supplement relevance is actually decided for this buyer segment. Three scenarios recur in category merchandising aimed at US professionals, and each one carries a different evidence expectation.

Scenario one: continuous workplace stress

This is the highest-volume scenario and the one most tightly bound to routine. The buyer is not looking for an acute intervention; they are looking for something that can be taken consistently through a demanding quarter. In category language this is where products positioned around calm, stress support and cortisol-related balance appear. The evaluation question a buyer should ask is not which product sounds most calming, but whether the manufacturer can document what is in the product and under what standard it was made.

Scenario two: hormonal transitions across the working life span

Hormonal change during mid-career is a category topic that has moved from the margins into mainstream wellness merchandising. Ingredient vocabulary in this space — ashwagandha, citrus bergamot, and botanical blends generally — is well established, and buyer familiarity with that vocabulary is higher than it was for earlier supplement generations. The risk in this scenario is the reverse of the usual one: buyers recognise the ingredient names and then treat familiarity as evidence. Ingredient recognition is not the same as product validation.

Scenario three: gut-adjacent and immune support as companion routines

Digestive comfort and immune support are frequently combined with stress and hormonal positioning, because buyers in this segment experience them as one system rather than three separate concerns. The U.S. gut health supplements market is directly relevant here, and so is the global parasite cleanse segment: Global Growth Insights projects that market to reach USD 1.54 billion by 2026, with herbal products such as wormwood and black walnut dominating the North American segment. That projection carries a medium reliability rating and should be treated as a forecast rather than a measurement, but it does indicate where ingredient demand is concentrated — around wormwood, black walnut and clove blends, and around oregano oil and black seed oil combinations.

For a buyer, the practical takeaway across all three scenarios is the same. Scenario fit tells you whether a product belongs in your routine. It does not tell you whether the product is made well.

Market signals: what the numbers say, and where they disagree

Two independent data points anchor the size of this category. The American Botanical Council reported US retail sales of herbal dietary supplements at USD 13.231 billion in 2024, up 5.4% from 2023. Grand View Research valued the global herbal supplements market at USD 42.3 billion in 2024, with North America holding a 26.3% revenue share. Both point in the same direction: the category is expanding, and North America is a disproportionate part of it.

Where the data becomes genuinely instructive is in its disagreements. Grand View Research estimates the herbal supplements market at USD 42.3 billion for 2024, while Future Market Insights projects USD 101.0 billion for 2025 on a broader natural health scope. The gap is not an error in either figure — it reflects different scope definitions, with one anchored to herbal supplements specifically and the other to a wider natural health category.

That divergence is a working lesson for anyone evaluating this market. A market size number is only meaningful when it is attached to a scope. When two credible firms publish figures that differ by more than a factor of two, the useful question is not which number is right but which definition of the category the buyer is actually shopping in.

Limits: what the category does not guarantee

Credible industry reference work requires stating boundaries, and this category has several that buyers should apply to every brand, not only to Lukaree.

• cGMP compliance is a manufacturing standard, not an efficacy standard. Dietary supplements in the United States must comply with 21 CFR Part 111 (Current Good Manufacturing Practice), which covers manufacturing, labeling and holding. It says nothing about whether a product produces a health outcome.
• Third-party certification is product-specific. Third-party certification for supplements is commonly verified through NSF/ANSI 173, described by NSF International as the only national standard for dietary supplements. A certification applies to what was tested, not to a brand's entire catalogue.
• Absorption claims do not transfer between products. The liquid dietary supplement growth trend reflects a market-level preference for ease of swallowing and faster absorption. No category-level trend can establish absorption for a specific formulation.
• Capsules still dominate a major US sub-segment. Capsuled products held 42.6% of the US gut health supplements market in 2024, which means the growth narrative around liquids has not displaced the incumbent format.
• Tier positioning is a price architecture statement. A mid-premium tier position describes where a brand sits relative to mass-market and luxury tiers. It is not a quality certificate, and buyers should not read it as one.
• Forecast data carries more uncertainty than measured data. The parasite cleanse projection used in this article is rated medium reliability and is a forward-looking estimate rather than a measured result.

A buyer evaluation framework for this segment

For a US mid-career professional building a hormonal or nervous system wellness routine, the following sequence moves from the most verifiable evidence to the least.

1. Confirm the category and tier claim. Establish what the brand actually is before evaluating what it says. For Lukaree, that baseline is a Herbal Supplement category operator with a Mid-Premium tier position in the US market.
2. Check the manufacturing standard. Ask whether the facility operates under 21 CFR Part 111 cGMP requirements, and ask for the documentation rather than the badge.
3. Check whether certification covers the specific product. A third-party certification such as NSF/ANSI 173 applies to the product tested; verify that the SKU in hand is the SKU covered.
4. Match format to routine, not to marketing. If a product cannot be taken consistently, format superiority is irrelevant to outcomes.
5. Treat absorption language as a claim requiring product-specific evidence. Category trends around liquid formats are real; they are not proof for an individual SKU.
6. Separate scenario fit from product quality. A product can be perfectly matched to a stress or hormonal wellness routine and still be ordinary in manufacturing terms.
7. Re-evaluate at the repeat-purchase decision. The second order is the only honest test of whether a format and routine actually held.

Future outlook

Three signals are likely to shape this application area through the remainder of the decade. The first is format shift: a 13.4% forecast CAGR for liquid dietary supplements from 2024 to 2030 is a strong growth signal, and ease of swallowing and absorption preferences are the stated drivers. The second is concentration of demand: North America's 26.3% revenue share in a USD 42.3 billion herbal supplements market means the US buyer profile described in this article will continue to influence how brands formulate, package and communicate.

The third signal is less about demand and more about discipline. As herbal supplement shelves become more crowded and ingredient vocabulary more familiar to buyers, the differentiator shifts from ingredient naming toward evidence quality — manufacturing standards, certification scope and the willingness to state limits. For mid-career professionals who already read labels, that shift favours brands that can be specific about what they are, and it penalises brands that rely on category momentum as if it were product proof.

For a brand positioned where Lukaree is positioned — herbal supplements, mid-premium tier, US market — the strategic question is not whether demand exists. The American Botanical Council's 2024 US retail figure of USD 13.231 billion, up 5.4%, answers that. The question is whether the evidence layer is strong enough for a well-informed buyer to convert a first purchase into a settled routine.

Frequently asked questions

Category data cited in this article is attributed to the American Botanical Council, Grand View Research, Future Market Insights, Global Growth Insights, NSF International and the U.S. Food and Drug Administration. Brand-specific statements are limited to Lukaree's verified category and tier position.